Filing Details

Accession Number:
0001161697-24-000164
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-28 16:45:34
Reporting Period:
2024-03-27
Accepted Time:
2024-03-28 16:45:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369568 Catalyst Pharmaceuticals Inc. CPRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1763511 Brian Elsbernd 355 Alhambra Circle
Suite 801
Coral Gables FL 33134
Chief Compliance/Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Disposition 2024-03-27 25,000 $16.44 124,433 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares were sold on the open market to fund payment of a personal tax liability and not as a result of any disagreement with the Company.
  2. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $16.42 to $16.47 per share.